Modular Solution for Cosmetics Compliance
Check the Conformity of your Formulas
Secure your regulatory documents for each zone
Optimize on-site risk management
Manage your Safety Data Sheets efficiently
Automate your regulatory monitoring
Ensure the traceability of your substances
Maintain good HSE risk management
Active substance renewal under the GB Biocidal Products Regulation (GB BPR) is a critical regulatory challenge for companies placing biocidal products on the Great Britain market. With strict 550-day submission deadlines and major expiries in 2026 and 2027, early planning is essential to avoid market disruption and loss of product authorisations.
Recevez une fois par mois les dernières actus réglementaires et conseils d’experts.
Learn about the "same" biocidal product Marketing Authorisation (MA) process, from wider to narrower authorisations or markets. Find out how to submit a dossier, the evaluation process, supporting documents, and linked fees. Explore more on biocidal products' regulation in Europe.
The simplified authorisation procedure promotes the use of environmentally friendly biocidal products by ensuring they meet specific criteria, such as containing no substances of concern or nanomaterials. Once authorised, these products can be marketed across Member States with minimal fees.
Learn about the 3 registration deadlines set by REACH for chemical substances, the changes it brought to industrial practices, and what to expect next in terms of chemical safety regulations in the EU. Stay compliant and keep up with evolving requirements.
Learn about the national marketing authorisation process for products in a single state, including mutual recognition procedures, dossier submission, evaluation, and supporting documents. Understand the role of competent authorities and the potential fees involved.
EcoMundo excels in assisting companies with REACH Authorisation requests, with a 100% success rate since 2015. Their team offers expert guidance, adaptability, unique methodology, and ongoing support for a successful outcome.
Union authorisation allows companies to market biocidal products across the EU with a single approval, bypassing national authorisations. The process involves dossier submission, evaluation by competent authorities, and a final decision by the European Commission.
